Nowak et al. [27] compared panel sequencing results from unselected colorectal carcinomas with immunohistochemical and MSI data and found that false negative results relative to MSI were attributable to tumor heterogeneity, whereas false positive results were explained by POLE mutations. The gene discussed is POLE; the disease is colorectal carcinoma.